Additional file 1: of Indacaterol/glycopyrronium is cost-effective compared to salmeterol/fluticasone in COPD: FLAME-based modelling in a Swedish population BjermerLeif van BovenJob Costa-ScharplatzMadlaina KeiningerDorothy GutzwillerFlorian LisspersKarin MahonRonan OlssonPetter RocheNicolas 2017 Methods and Results (additional details) (ZIP 535 kb)